IL316410A - Blumosodil for the treatment of chronic pulmonary allograft dysfunction - Google Patents
Blumosodil for the treatment of chronic pulmonary allograft dysfunctionInfo
- Publication number
- IL316410A IL316410A IL316410A IL31641024A IL316410A IL 316410 A IL316410 A IL 316410A IL 316410 A IL316410 A IL 316410A IL 31641024 A IL31641024 A IL 31641024A IL 316410 A IL316410 A IL 316410A
- Authority
- IL
- Israel
- Prior art keywords
- belumosudil
- treating chronic
- chronic lung
- lung allograft
- allograft dysfunction
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263332628P | 2022-04-19 | 2022-04-19 | |
| US202263389444P | 2022-07-15 | 2022-07-15 | |
| PCT/US2023/018952 WO2023205153A1 (en) | 2022-04-19 | 2023-04-18 | Belumosudil for treating chronic lung allograft dysfunction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL316410A true IL316410A (en) | 2024-12-01 |
Family
ID=86330932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL316410A IL316410A (en) | 2022-04-19 | 2023-04-18 | Blumosodil for the treatment of chronic pulmonary allograft dysfunction |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250255867A1 (https=) |
| EP (1) | EP4511036A1 (https=) |
| JP (1) | JP2025513240A (https=) |
| KR (1) | KR20250003657A (https=) |
| CN (1) | CN119031914A (https=) |
| AU (1) | AU2023256541A1 (https=) |
| CA (1) | CA3249201A1 (https=) |
| IL (1) | IL316410A (https=) |
| MX (1) | MX2024012802A (https=) |
| TW (1) | TW202404602A (https=) |
| WO (1) | WO2023205153A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL325938A (en) * | 2023-07-17 | 2026-03-01 | Kadmon Corp Llc | Combination therapy including BTK inhibitor and BELUMOSUDIL |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR9465A (es) | 2005-03-25 | 2008-06-19 | Surface Logix Inc | Compuestos mejorados farmacocineticamente |
| CN113620933A (zh) | 2012-10-05 | 2021-11-09 | 卡德门企业有限公司 | Rho激酶抑制剂 |
| US11311541B2 (en) * | 2014-04-09 | 2022-04-26 | Kadmon Corporation, Llc | Treatment of GVHD |
-
2023
- 2023-04-18 KR KR1020247036230A patent/KR20250003657A/ko active Pending
- 2023-04-18 JP JP2024560674A patent/JP2025513240A/ja active Pending
- 2023-04-18 CA CA3249201A patent/CA3249201A1/en active Pending
- 2023-04-18 WO PCT/US2023/018952 patent/WO2023205153A1/en not_active Ceased
- 2023-04-18 TW TW112114416A patent/TW202404602A/zh unknown
- 2023-04-18 CN CN202380033867.4A patent/CN119031914A/zh active Pending
- 2023-04-18 AU AU2023256541A patent/AU2023256541A1/en active Pending
- 2023-04-18 US US18/857,543 patent/US20250255867A1/en active Pending
- 2023-04-18 EP EP23723019.8A patent/EP4511036A1/en active Pending
- 2023-04-18 IL IL316410A patent/IL316410A/en unknown
-
2024
- 2024-10-16 MX MX2024012802A patent/MX2024012802A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023205153A1 (en) | 2023-10-26 |
| JP2025513240A (ja) | 2025-04-24 |
| US20250255867A1 (en) | 2025-08-14 |
| CN119031914A (zh) | 2024-11-26 |
| TW202404602A (zh) | 2024-02-01 |
| AU2023256541A1 (en) | 2024-12-05 |
| CA3249201A1 (en) | 2023-10-26 |
| EP4511036A1 (en) | 2025-02-26 |
| MX2024012802A (es) | 2024-11-08 |
| KR20250003657A (ko) | 2025-01-07 |
| AU2023256541A2 (en) | 2024-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285999A (en) | jak1 inhibitor pathway for the treatment of impaired chronic lung allograft function | |
| GB202306469D0 (en) | Methods | |
| IL316410A (en) | Blumosodil for the treatment of chronic pulmonary allograft dysfunction | |
| GB202210325D0 (en) | Methods | |
| GB202205881D0 (en) | Methods | |
| PL4048284T3 (pl) | Metoda leczenia nowotworów | |
| HK40122725A (en) | Belumosudil for treating chronic lung allograft dysfunction | |
| GB202210902D0 (en) | Sorbent | |
| PT3645735T (pt) | Métodos e composições para prever disfunção crónica de aloenxerto pulmonar | |
| PL4010303T3 (pl) | Mieszanina do obróbki wzmacniającej powierzchnię | |
| IL304221A (en) | A method for treating chronic kidney diseases | |
| GB202217332D0 (en) | Methods | |
| HK40067155A (en) | Jak1 pathway inhibitors for the treatment of chronic lung allograft dysfunction | |
| SMT202200103T1 (it) | Metodo di fabbricazione di pannelli in legno massiccio multistrato | |
| CA223145S (en) | Weir | |
| CA223136S (en) | Weir | |
| CA217503S (en) | Pool | |
| CA213070S (en) | Pool cue canister | |
| GB2628034B (en) | Finishing apparatus | |
| CA232489S (en) | Straight rail | |
| GB202316617D0 (en) | Formation method | |
| ZA202105056B (en) | Method for chemically inducing allotriploid abalone | |
| GB202405283D0 (en) | Decking | |
| GB202213314D0 (en) | Self-unblocking valve apparatus | |
| GB202318001D0 (en) | Double-spend checks |